Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid
- 31 January 1992
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 92 (1) , 41-47
- https://doi.org/10.1016/0021-9150(92)90008-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- N-acetylcysteine and immunoreactivity of lipoprotein(a)The Lancet, 1991
- Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjectsAtherosclerosis, 1991
- Lipoprotein (a) : structure, properties and possible involvement in thrombogenesis and atherogenesisAtherosclerosis, 1990
- Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic controlPublished by American Medical Association (AMA) ,1990
- Auswirkungen der Danazol-Therapie bei Endometriose auf Blutbild und GerinnungGeburtshilfe und Frauenheilkunde, 1988
- Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questionsAmerican Heart Journal, 1987
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- Treatment with danazol and plasma glucagon concentration.BMJ, 1985
- Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozololBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Lipoprotein (a) is not a metabolic product of other lipoproteins containing apolipoprotein BBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979